Evidence map›Paper›PMID 21294269›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2011

Ultrasensitive detection of low-abundance surface-marker protein using isothermal rolling circle amplification in a microfluidic nanoliter platform.

Tania Konry, Irina Smolina, Joel M Yarmush, Daniel Irimia, Martin L Yarmush

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Cell-Free Production Systems in Droplet Microfluidics.Advances in biochemical engineering/biotechnology · 2023
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Site-specific DNA-antibody conjugates for specific and sensitive immuno-PCR.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tania KonryCenter for Engineering in Medicine and Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Irina Smolina
Joel M Yarmush
Daniel Irimia
Martin L Yarmush

Funding

Bio-MicroElectroMechanical Systems Resource CenterP41EB002503 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET · 2004 to 2018
$17.4M
Ultra-specific In Situ Detection of Short Sequences in Human Genomic DNA under NoR21RR025371 · NCRR · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI SMOLINA, IRINA · 2009 to 2010
$605k
NCRR NIH HHS 1R21RR025371-01NCRR NIH HHS R21 RR025371NIBIB NIH HHS P41 EB002503
6 · The paper itself

Abstract

With advances in immunology and cancer biology, there is an unmet need for increasingly sensitive systems to monitor the expression of specific cell markers for the development of new diagnostic and therapeutic tools. To address this challenge, a highly sensitive labeling method that translates antigen-antibody recognition processes into DNA detection events that can be greatly amplified via isothermal rolling circle amplification (RCA) is applied. By merging the single-molecule detection power of RCA reactions with microfluidic technology, it is demonstrated that the identification of specific protein markers can be achieved on tumor-cell surfaces in miniaturized nanoliter reaction droplets. Furthermore, this combined approach of signal amplification in a microfluidic format could extend the utility of existing methods by reducing sample and reagent consumption and enhancing the sensitivities and specificities for various applications, including early diagnosis of cancer.

Indexed as

AnimalsBiomarkers, TumorHumansMembrane ProteinsMicrofluidicsNanotechnologyBiomarkers, TumorMembrane Proteins

Identifiers

PMID21294269
PMCPMC3110589

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.